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Regular) physical) activity) is) one) of) the) cornerstones) in) the) prevention) of) chronic)
diseases.)The)aim)of)this)study)was)to)assess)whether)a)former)career)as)a)male)elite)
athlete) associates) with) various) cardiometabolic) disorders) and) whether) it) has) any)
effect)on)leukocyte)telomere)length)in)later)life.))
The) original) study) population) (N=4136)) consists) of) 2424)male) former) elite) athletes)
and) 1712) matched) controls.) Of) those,) 599) (392) former) athletes,) 207) controls))
participated) in)a)clinical) study) in)2008.)The)athletes)were)divided) into) three)groups)
based)upon) their) previous) career:) endurance,)mixed) and)power) sports.) The) clinical)
study) in) 2008) included) a) physical) examination,) laboratory) tests,) and) several)
questionnaires.) Data) on) use) of) medication) was) obtained) from) the) Finnish) Social)
Insurance)Instituion.)
Among) the) participants,) the) former) elite) athletes) tend) to) have) lower) age[adjusted)
prevalence)of)type)2)diabetes)compared)with)the)controls)(odds)ratio)[OR])0.68,)95%)
confidence) interval) [CI]) 0.45[1.01).) ) The)male) former) athletes) also) had) lower) age[
adjusted)risk)for)hypertension)(OR)0.69,)95%)CI)0.49[0.98),)metabolic)syndrome)(OR)
0.57,)95%)CI)0.40[0.81),)and)non[alcoholic) fatty) liver)disease) (OR)0.61,)95%)CI)0.42[
0.88)) compared) to) the) controls.) The) former) athletes) had) significantly) lower) age[
adjusted) body) fat) percentage) compared) to) the) controls) (p=0.021)) whereas) no)
significant)differences)in)mean)age[adjusted)leukocyte)telomere)lenght)between)the)
athlete) and) control) groups) (p) =) 0.845)) were) observed.) Moreover,) with) aging) the)
former)athletes)maintained)their)physically)active)lifestyle)better)than)their)controls.)
A) male) former) elite) athlete) career) seems) to) protect) from) type) 2) diabetes,)
hypertension,)metabolic)syndrome,)and)non[alcoholic)fatty)liver)disease)at)older)age.)
It) was) also) associated) with) a) more) favorable) body) composition.) The) volume) of)




Säännöllinen) fyysinen) aktiivisuus) ennaltaehkäisee) merkittävästi) kroonisia)
elämäntapasairauksia.) Tämän) tutkimuksen) tarkoituksena) oli) selvittää,) suojaako)
miesten)nuoruusvuosien)huippu[urheilu) kardiometabolisilta) sairauksilta) ja)onko) sillä)
vaikutusta)valkosolujen)telomeeri)[pituuteen)myöhemmällä)iällä.)
Alkuperäinen)tutkimusväestö)(N=4136))koostui)ikääntyneistä)mieshuippu[urheilijoista)
(n=2424)) sekä) heidän) verrokeistaan) (n=1712).) Terveystutkimukseen) vuonna) 2008)
osallistui)599)henkilöä,) joista)392)oli)huippu[urheilijoita) ja)207)verrokkeja.)Urheilijat)
jaettiin)nuoruusiän)urheilu[uran)perusteella)kestävyys[,)joukkue[)ja)voimaurheilijoihin.)
Terveystutkimukseen) sisältyi) terveystarkastus,) laboratoriokokeita) sekä)




1.01).) Vastaavasti) ikääntyneillä) huippu[urheilijoilla) oli) alhaisempi) ikävakioitu)
kohonneen)verenpaineen)(riskisuhde)0.69,)95%)luottamusväli)0.49[0.98),)metabolisen)
oireyhtymän) (riskisuhde)0.57,)95%) luottamusväli) 0.40[0.81)) sekä)ei[alkoholiperäisen)
rasvamaksan) (riskisuhde) 0.61,) 95%) luottamusväli) 0.42[0.88)) riski) kuin) verrokeilla.)
Ikääntyneiden)huippu[urheilijoiden)ikävakioitu)kehon)rasvaprosentti)oli)merkittävästi)
alhaisempi) kuin) verrokeilla) (p=0.021),) sen) sijaan) ikävakioidussa) valkosolujen)
telomeeri)[pituudessa)ei)tullut)esiin)merkittävää)eroa)(p)=)0.845).)Miehet,)jotka)olivat)
olleet) nuoruudessa) huippu[urheilijoita,) olivat) iäkkäinä) elintavoiltaan) fyysisesti)
aktiivisempia)kuin)verrokit.)))
Ura) mieshuippu[urheilijana) näyttää) suojaavan) tyypin) 2) diabetekselta,) kohonneelta)
verenpaineelta,) korkealta) kehon) rasvaprosentilta,) metaboliselta) oireyhtymältä) sekä)





Non[communicable)diseases) are)major) killers) globally) and) kill)more) than)36)million)
people) each) year) (Lim) et) al.,) 2012).) The) four) major) non[communicable) diseases)
include) cardiovascular) disease,) cancers,) chronic) respiratory) diseases,) and) diabetes)
(1,2).)In)Western)Europe,)the)major)risk)factors)underlying)these)diseases)are)tobacco)
smoking) including)passive) smoking,)high)blood)pressure) (BP),)high)body)mass) index)
(BMI),) excessive) alcohol) intake,) and) physical) inactivity.) Further,) elevated) fasting)
glucose) concentration,) elevated) total) cholesterol) concentration,) and) an) unhealthy)
diet)contribute)to)the)disease)burden)(Lim)et)al.,)2012;)Yusuf)et)al.,)2001a;)Yusuf)et)




factors.)This) is)mostly)because)of) the)aging)population,) substantial) achievements) in)
lowering)mortality) among) children) less) than) five) years) of) age,) and) changes) in) risk)
factor)exposure)(Lim)et)al.,)2012).)
Regular)physical)activity)is)associated)with)a)multitude)of)health)advantages)including)
a) reduced) risk) for) cardiovascular) disease,) hypertension) and) type) 2) diabetes) (T2D))
(Bassuk)and)Manson,)2005;)Dickinson)et)al.,)2006;)Kohl,)2001;)Lindstrom)et)al.,)2013;)
Paffenbarger) et) al.,) 1991).) Consequently,) for) the) prevention) of) chronic) diseases,)
physical)activity)plays)a)major)role.)The)volume)of)leisure)time)physical)activity)(LTPA))
is) largely) influenced) by) various) periods) and) events) during) the) life) course) e.g.)
transition)to)university,)getting)married)or)retirement)(Allender)et)al.,)2008;)Engberg)
et) al.,) 2012).) ) However,) there) is) only) little) research) on) the) effects) and) on) the)
importance)of)LTPA)during)different)periods)of)life)from)a)life)course)perspective.)For)
example,)whether) physical) activity) during) adolescent) life) is)more) or) less) important)






(Shammas,) 2011).) Therefore,) morbidity) and)mortality) may) also) be) associated) with)
telomere)length)(Hastie)et)al.,)1990;)Ludlow)and)Roth,)2011;)Salpea)and)Humphries,)
2010;) Shammas,) 2011;) Wong) and) Collins,) 2003).) Smoking,) an) unhealthy) diet) and)
adiposity) have) all) been) linked) with) telomere) shortening) (Ornish) et) al.,) 2013;)
Shammas,)2011;)Tiainen)et)al.,)2012;)Woo)et)al.,)2010).)
In)Finland,)a)questionnaire[based)study)including)male)former)elite)athletes)and)their)
matched) controls) was) initiated) in) 1985.) Twenty[three) years) later) in) 2008,) living)
participants) took) part) in) a) clinical) study) including) a) physical) examination) and)
laboratory) tests) as) well) as) questionnaires.) Male) former) elite) athletes) have) a)
documented) history) of) vigorous) physical) activity) in) their) past,) generally) spanning)







of) the) skeletal) muscles) that) increase) energy) expenditure) (Caspersen) et) al.,) 1985;)
Howley,) 2001;)Mälkiä,) 1983).) Physical) activity) can) be) divided) into) different) groups)
including) occupational) physical) activity,) commuting) physical) activity,) household)
activities,)sleep,)and)LTPA)(Caspersen)et)al.,)1985;)Howley,)2001;)Warms,)2006).)LTPA)
describes)an)individual’s)activities)during)leisure)time)differing)according)to)personal)
interests) and) needs) (Howley,) 2001).) One) subcategory) of) LTPA) is) exercise) training,)
which) can) be) defined) as) planned,) structured) and) repetitive) bodily) movements)




activity) varies) from) person) to) person) and) from) efficiency) or)manner) of)movement)
(Lamonte)and)Ainsworth,)2001;)Warms,)2006).)
Of)total)daily)energy)expenditure)60[75)%)is)accounted)for)by)resting)metabolic)rate;)
the) energy) expended) for) the) maintenance) of) basic) physiologic) homeostasis)
(Poehlman,) 1992;) Ravussin) et) al.,) 1986).) About) 10) %) of) the) total) daily) energy)
expenditure)is)accounted)for)by)thermic)response)to)a)meal;)the)energy)expenditure)
associated)with)meal)ingestion)and)heat)production)(Poehlman,)1992).)The)remaining)
component) of) daily) energy) expenditure) is) physical) activity) including) shivering,)
fidgeting) and) purposeful) physical) exercise) (Poehlman,) 1992;) Ravussin) et) al.,) 1986).)
Energy) expenditure) and) hence) energy) requirements) varies) largely) between)
individuals,) the) type) and) amount) of) physical) activity) being) the) most) dominant)
(Dauncey,) 1990;) Howley,) 2001;) Ravussin) et) al.,) 1986).) The) association) between)
) 11)
physical) activity) and) energy) expenditure) is) strong;) in) addition) to) resting)metabolic)
rate) and) thermic) response,) a) sedentary) individual) can) use) only) 100) kilocalories) on)
physical)activity) in)a)day)whereas)an)endurance[trained)athlete)can)use)up) to)a)30[
fold) amount) of) kilocalories) daily) (Poehlman,) 1992).) Resting)metabolic) rate,) thermic)
effect)of)food)and)physical)activity)are)all)influenced)by)the)aging)process)(Poehlman)
and) Horton,) 1990).) It) has) been) estimated) that) in) young) individuals) the) total) daily)
energy)expenditure)is)3100)kilocalories)in)a)day)whereas)among)older)individuals)that)




of) interests.) In) addition,) the)methods) differ) largely) both) regarding) to) accuracy) and)
feasibility) but) also) in) relation) to) costs.!The) “gold) standard”)methods) for)measuring)
energy) expenditure) include) doubly) labeled) water,) direct) and) indirect) calorimetery)
(Warms,)2006).))Common)for)these)methods)is)high)accuracy)and)high)cost,)inhibition)
of) normal) activity,) need) for) special) equipment) and) trained) personnel,) and)
applicability)primarily) to) small) cohorts) (Dishman)et)al.,)2001;)Warms,)2006).) )Direct)
observation)can)also)be)considered)a)“gold)standard”)method,)which)provides)specific)
information) about) the) type,) duration) and) frequency) of) physical) activity,) but) no)
information) about) energy) expenditure) (Dishman) et) al.,) 2001;) Warms,) 2006).) In)
addition,) this) method) is) limited) to) space,) time) and) rating) scale,) suitable) for) small)
cohorts)and)needs)trained)personnel)(Dishman)et)al.,)2001;)Warms,)2006).)Heart)rate)









estimate,) about) environment,) subcategory,) type,) frequency,) duration,) and) intensity)
of) physical) activity) (Shephard,) 2003).) Presently) it) is) impossible) to) have) that)
information)individually)with)objective)methods.)A)drawback)of)these)methods)is)that)
individuals)both)over[estimate)and)under[estimate)their)own)physical)activity)(Prince)

















Data) Group,) 1979).) These) have) later) been) endorsed) and) redefined) several) times.)
There)have)been)other)definitions)of)diabetes)put)forward)by)different)organizations)
including) the)American)Diabetes)Association) and) International)Diabetes) Federation.)
Today,)diabetes)and)other)hyperglycemic)states)are)diagnosed)according)to)elevated)



















) ) ) ≥)11.1)








Table) 1) shows) the) diagnostic) criteria) for) impaired) fasting) glucose) (IFG),) impaired)
glucose) tolerance) (IGT))and)diabetes)according) to) the)WHO)and)American)Diabetes)
Association)criteria)(ADA,)2015;)WHO,)2006;)WHO,)2011).)In)Finland,)the)diagnosis)of)
hyperglycemic)states)is)based)upon)the)WHO)criteria))(Current)care)Diabetes,)2013).)
Above) these) glucose) values,) the) risk) of) future) development) of) micro[) and)
macrovascular) complications) is) elevated) (DECODE) Study) Group,) European) Diabetes)
Epidemiology)Group,)2003;)Levitan)et)al.,)2004;)Sorkin)et)al.,)2005;)WHO,)2006).)
Worldwide,) the)prevalence)of)diabetes) is) estimated) to) increase) from)382)million) in)
2013) to)592)million) individuals)by)2035)and) is)mainly)attributable) to)an) increase) in)
T2D,)which)represents)about)90[95)%)of)all)cases))(IDF)Diabetes)Atlas,)2013).)Figure)1)
gives) prevalence) rates) of) diabetes) in) some) selected) countries) or) territories) in) the)
adult) population) aged) 20[79) years.) Some) underlying) factors) explaining) the) rapid)
increase)in)T2D)include)aging)of)world)population,)changes)in)lifestyle,)environmental)
and)genetic)factors)(Chen)Lei,)Magliano)Dianna)J,)Zimmet)Paul)Z,)2012;)Danaei)et)al.,)











In) Finland,) the) estimated)number)of) individuals)with)diabetes) is) approximately) 500)
000,)and)of)those)85)%)have)type)2)diabetes)(Koski)Sari,)2011).)Further,)according)to)a)
Finnish)population)based)study)performed)in)almost)3000)adults)aged)45)–)74)years)
the) prevalence) of) IFG) was) 9) %) in) men) and) 5) %) in) women,) respectively) while) the)
prevalence)of) IGT)was)15)%)and)16)%,)and)that)of)T2D)16)%)and)11)%,)respectively)
(Peltonen)et)al.,)2006).)Overall)abnormal)glucose) regulation)was)present) in)42)%)of)
the) men) and) in) 33) %) of) the) women) (Peltonen) et) al.,) 2006).) Further,) it) has) been)
estimated) that) the) absolute) annual) incidence) of) diabetes) in) individuals)with) IFG)or)
IGT)varies)from)5)to)10)%)(Gerstein)et)al.,)2007).)
In) Europe,) the) prevalence) of) T2D) and) IGT) increases) both) in)men) and)women)with)
aging) (Peltonen)et)al.,)2006;)Qiao)et)al.,)2005;)Whiting)et)al.,)2011).)With) regard) to)
) 15)




Plasma) glucose) concentration) depends) on) the) rate) of) glucose) entering) into) the)
circulation) balanced) by) the) rate) of) glucose) disposal) from) the) circulation) (Gerich,)
2000).) In) the) fasting) state,) the) liver) is) responsible) for) about) 75) %) to) 80) %) of) the)
glucose) released) into) the) circulation) and) the) remaining) 20) %) to) 25) %) of) glucose)
originates)from)kidney)gluconeogenesis)(Stumvoll)et)al.,)1997).)Glucose)metabolism)is)
normally) regulated) by) a) feedback) loop) including) insulin[sensitive) tissues,) including)
liver,)muscle)and)adipose)tissue,)and)pancreatic)islet)cells)(Kahn)et)al.,)1993;)Kahn)et)
al.,) 2014;) Shulman,) 2014).) Prevailing) insulin) sensitivity) determines) the) amount) of)
insulin) released) from) pancreatic) β[cells) to) maintain) normal) glucose) tolerance)
(Goodyear)and)Kahn,)1998;)Kahn)et)al.,)2014).)Insulin)interacts)in)the)liver)suppressing)
hepatic)glucose)production)(Kahn)et)al.,)2014).)Further,)in)muscles)and)adipose)tissue)
insulin) stimulates) the) uptake) of) glucose,) amino) acids,) and) fatty) acids) (Kahn) et) al.,)
2014).) ) The) mediators) of) these) mechanisms) are) still) partly) unknown,) but) include)
integration) between) neuronal) and) humoral) systems) (Kahn) et) al.,) 2014).) If) insulin)
resistance)is)present,)in)the)other)words)if)cells)fail)to)respond)to)the)normal)action)of)
insulin,) pancreatic) β[cells) increase) their) insulin) output) to) maintain) normal) glucose)
levels,)which)leads)to)hyperinsulinemia)(Kahn)et)al.,)2014).)However,)if)β)cells)fail)with)
this) task,)plasma)concentrations)of)glucose) increase) leading)to)hyperglycemia) (Kahn)
et)al.,)2014).))
Although) there) is) a) classification) separating) IFG,) IGT) and) T2D,) these) disturbances)
create) a) continuum)where) the)magnitude) of) impaired) pancreatic) islet) cell) function)
influences) the) degree) of) increase) in) plasma) glucose) concentration) (Shulman,) 2014;)






Genes) and) environmental) factors) are) important) determinants) of) both) insulin)
resistance)and)impaired)β[cell)function,)both)hallmarks)of)manifest)T2D)(Elbein)et)al.,)
1999;) Kahn) et) al.,) 2014;) Laakso) and) Kuusisto,) 2014). Since) 2007,) genome[wide)
association) studies) have) identified) over) 70) genetic) variants,) single) nucleotide)
polymorphisms,)increasing)the)risk)of)T2D)by)10[30)%)(DIAbetes)Genetics)Replication)
And)Meta[analysis) (DIAGRAM))Consortium)et) al.,) 2014;) Lyssenko)and) Laakso,) 2013;)
McCarthy,)2010;)Morris)et)al.,)2012).)Most)genes)are)associated)with)β[cell)function,)
while) some) are) associated) with) insulin) resistance) and) obesity) (McCarthy,) 2010).))
Several) other) factors,) including)pancreatic) glucolipotoxicity) and) amyloid)deposition,)
ectopic)lipid)accumulation,)effect)of)intestinal)peptides)and)microbiome,)dysfunction)
of) neurotransmitters,) increased) renal) glucose) reabsorption) and) systemic) and) islet)


























composition) of) nutrition,) decreased) energy) expenditure,) in[utero) environmental)
factors,) and) environmental) chemicals) seem) to) have) an) essential) role) in) the)
development) of) T2D) (Defronzo,) 2009;) Eriksson,) 2011;) Kahn) et) al.,) 2014;) Shulman,)
2014).)The)pathogenesis)of)T2D)is)illustrated)in)Figure)2.)
2.2.3 RISK!FACTORS!





al.,) 1981;) Wang) et) al.,) 2005).) In) addition,) degree) and) duration) of) overweight) or)
obesity)positively) influence)risk)of)T2D)(Field)et)al.,)2001;)Schienkiewitz)et)al.,)2006;)
Wannamethee)and)Shaper,)1999).))For)example,)during)10)years)of)follow[up)among)




The) association) of) physical) inactivity) and) T2D) has) been) known) since) early) 1900)













































drug) treatment.)Drug) treatment) includes)oral)drugs)and) if) needed) injectable)drugs.)
The) treatment) goal) is) to) prevent) acute) complications,) long[term) diabetic)








all) contracting) skeletal) muscles,) glucose) is) an) important) fuel.) When) shifting) from)
resting) condition) to) exercise,) enhancement) of) glycogenolysis) and) gluconeogenesis,)
and)mobilization) of) alternative) fuels) including) free) fatty) acid) increase) liver) glucose)
production)(Colberg)et)al.,)2010;)Galbo)et)al.,)1975;)Richter)and)Hargreaves,)2013;)Suh)




al.,) 1988;) Suh) et) al.,) 2007).) With) prolonged) exercise,) the) contribution) of)
gluconeogenesis) raises) more) important) (Suh) et) al.,) 2007).) Further,) glucose) uptake)
into)active)muscles)is)increasing)with)physical)activity)(Richter)and)Hargreaves,)2013;)








capillaries) as) well) as) in) the) translocation) and) expression) of) GLUT4) –transporters)
enabling)glucose)transport)into)skeletal)muscle)(Andersen)and)Saltin,)1985;)Kennedy)
et) al.,) 1999;) Richter) and) Hargreaves,) 2013).) Regular) exercise) training) increases)
skeletal)muscle)GLUT4)expression,)but)the)responses)vary)greatly)between)individuals)
(Houmard) et) al.,) 1993).) Aerobic) and) resistance) training) are) both) potent) stimuli) to)
increase)muscle)GLUT4)expression,)thus)enhancing)insulin)sensitivity,)glucose)disposal)
and) muscle) glycogen) storage) in) healthy) individuals) as) well) as) in) people) with) T2D)
(Christ[Roberts) et) al.,) 2004;) O'Gorman) et) al.,) 2006;) Richter) and) Hargreaves,) 2013).)
Also)insulin)stimulates)GLUT4)translocation)but)through)distinct)signaling)mechanism)
(Stanford) and) Goodyear,) 2014).) Further,) individuals) involved) in) regular) endurance[
type)exercise)are)known)to)have)a)higher)proportion)of) type)1)muscle) fibers,)which)
has)been)associated)with)better) insulin) sensitivity) (Costill) et) al.,) 1976;) Lillioja)et) al.,)
1987;) Lundsgaard) and) Kiens,) 2014).)Moreover,) physical) exercise) is) associated) with)
restoration)of)mitochondrial)function)thus)improving)muscle)insulin)sensitivity)(Meex)
et) al.,) 2010;) Phielix) et) al.,) 2012).) Finally,) acute) exercise) increases) muscle) glucose)
uptake)via)activating)alternative)molecular)signals)enabling)bypass)defects) in) insulin)
signaling) in) skeletal) muscle) whereas) chronic) exercise) training) improves) muscle)





2015).) With) the) present) understanding,) deoxyribonucleid) acid) (DNA))
hypomethylation) is) associated) with) the) exercise) response) in) skeletal) muscle;) DNA)




















Optimal) <)120) and) <)80)
Normal) 120[129) and/or) 80[84)
High)normal) 130[139) and/or) 85[89)
Grade)1)hypertension) 140[159) and/or) 90[99)
Grade)2)hypertension) 160[179) and/or) 100[109)
Grade)3)hypertension) ≥)180) and/or) ≥)110)










Office)) ≥)140) and/or) ≥)90)





















Worldwide,) the) prevalence) of) hypertension) (based) on)measured) systolic) BP) ≥) 140)
mmHg)or)diastolic)BP)≥)90)mmHg)or)use)of)medication)to)treat)hypertension))is)38)%)
among)adults)over)25) years,) 39)%) in)men)and)36)%) in)women,) respectively) (WHO,)















understanding,) the)major) pathophysiological)mechanism)underlying)hypertension) is)
autonomic) imbalance,) including) sympathetic) hyperactivity) and) parasympathetic)
underactivity,)as)well)as)activation)of)the)renin[angiotensin[aldosterone)(RAA))system)
(Brook) and) Julius,) 2000;) Heilpern,) 2008;) Mark,) 1996;) Oparil) et) al.,) 2003).) The)
activation)of) the)sympathetic) system,)causing) for)example)an) increase) in)heart) rate)
and)increased)vascular)resistance,)contributes)to)elevated)BP)and)to)the)development)
of)hypertension)(Brook)and)Julius,)2000;)Mark,)1996).)Autonomic)imbalance)seems)to)
have) an) association)with) several)metabolic,) hemodynamic,) thrombotic) and) trophic)
abnormalities)(Brook)and)Julius,)2000).)Activation)of)the)RAA[system)increases)BP)by)
various)mechanisms,)which)leads)to)cardiovascular)hypertrophy,)release)of)cytokines)
and) sodium) and) water) retention) (Heilpern,) 2008;) Oparil) et) al.,) 2003).) Other)
underlying) pathophysiological) factors) include) overproduction) of) sodium[retaining)
hormones) and) vasoconstrictors,) long[term) high) dietary) sodium) intake,) inadequate)
dietary)potassium)and) calcium) intake,)deficiencies) among)endogenous) vasodilators,)
alterations) in) expression) of) the) kallikrein[kinin) system,) abnormalities) of) resistance)




Several)studies)have)shown)a) link)between)raised)BP)and) life[style) factors) (Appel)et)
al.,) 1997;) Beilin,) 1999;) Dickinson) et) al.,) 2006).) Among) the) major) risk) factors) are)
overweight) and) obesity,) which) have) a) strong) correlation) with) unhealthy) dietary)




Rouse)et) al.,) 1983;) Yusuf) et) al.,) 2001b).) Table) 5) shows) risk) factors) for) elevated)BP.))






























Treatment) for) hypertension) includes) lifestyle) changes,) which) include) dietary)
modification,) increase) in) exercise,) and/or) weight) reduction) as) well) as)
antihypertensive) drug) treatment.) The) treatment) goal) is) to) prevent) cardiovascular)
morbidity)and)mortality)often)associated)with)untreated)hypertension.)Although)the)
same) definitions) and) classifications) for) hypertension) are) applied) among) elderly)




Physical) activity) levels) usually) show) positive) associations) with) the) prevention,)
treatment) and) control) of) hypertension) (Balducci) et) al.,) 2014;) Bauer) et) al.,) 2014;)
Bouchard)et)al.,)2012;)Fagard,)1999;)Fagard,)2005;)Halbert)et)al.,)1997;)Paffenbarger)
et)al.,)1991;)Pescatello)et)al.,)2004).)Especially,)high)volume)of)LTPA)is)linked)to)lower)
BP) and) lower) risk) for) hypertension)whereas) that) relation) is) not) observed) between)
occupational) physical) activity) and) hypertension) (Barengo) et) al.,) 2005;) Huai) et) al.,)
2013;)Kujala)et)al.,)2011;)Paffenbarger)et)al.,)1991).)Aerobic)training)seems)to)lower)
BP) more) in) individuals) with) hypertension) than) in) normotensive) individuals)
(Cornelissen) and) Fagard,) 2005b).) Resistance) training) (mainly) dynamic) resistance)
training))seems)to)significantly)decrease)diastolic)BP)and)somewhat)systolic)BP,)and)




The) effects) of) exercise) on) BP) are) various) including) neurohumoral,) vascular) and)
structural) adaptations) however) also) underlying) genetic) factors) influence) the) effect)
(Pescatello) et) al.,) 2004;) Rankinen) et) al.,) 2000;) Rice) et) al.,) 2002).) ) Due) to) chronic)




contributes) to) a) reduction) in) peripheral) resistance) (Kingwell,) 2000;) Maeda) et) al.,)
2001).) Decreased) catecholamines,) ameliorated) insulin) sensitivity) and) arterial)
baroreflex) function) as) well) as) increased) number) of) precapillary) vessels) in) muscle)
tissue) are) examples) of) other) beneficial) effects) of) exercise) training) (Jennings) et) al.,)
1986;) Kohno) et) al.,) 2000;) Pescatello) et) al.,) 2004;) Somers) et) al.,) 1991).) Further,) it)
seems)that)genetic)factors)regulate)the)effects)of)exercise)training)upon)BP)(Rankinen)
et) al.,) 2000;) Rice) et) al.,) 2002).) Particularly,) among) endurance) athletes) low) BP) has)




Metabolic) syndrome) (MetS)) is) a) cluster) of)metabolic) disorders) including) abdominal)






used) definitions) have) been) proposed) by) WHO) in) 1999,) The) National) Cholesterol)
) 25)
Education) Program’s) Adult) Treatment) Panel) (NCEP:) ATP)) III) 2005,) International)
Diabetes) Federation) (IDF)) 2005) and) Joint) Interim) Statement) (Alberti) et) al.,) 2005;)
Alberti)et)al.,)2009;)Grundy)et)al.,)2005),)see)Table)6.)
The)prevalence)of)MetS)among)adults)ranges)between)5.6)%)and)68.6)%)depending)
on) the) characteristics) of) population) (e.g.) age,) gender,) ethnicity,) and) definition)
applied)) (Cameron) et) al.,) 2004;) Eckel) et) al.,) 2005;) Mozumdar) and) Liguori,) 2011;)
Vishram) et) al.,) 2014).) The) prevalence) is) highly) age[dependent) and) increases) with)
increasing) age) (Cameron) et) al.,) 2004;) Hu) et) al.,) 2008;) Ilanne[Parikka) et) al.,) 2004;)
Mozumdar) and) Liguori,) 2011;) Vishram) et) al.,) 2014).) According) to) an) IDF) estimate,)
one[quarter)of)the)world’s)adult)population)is)having)MetS)(IDF,)2005).)In)Europe,)the)
prevalence) of)MetS) was) 8.9) %) in) men) according) to) the) IDF) definition) and) 18.2) %)
according)to)NCEP:)ATP)III)definition,)and)in)women)20.8)%)and)22.3)%,)respectively)
(Vishram)et)al.,)2014).)Regardless)of)gender,)in)Europe)the)highest)prevalence)of)MetS)
was) among) individuals) aged) 60[78) years) (Vishram) et) al.,) 2014).) A) Finnish) study) in)
2002)assessing)individuals)aged)45[64)years,)reported)a)prevalence)of)MetS)according)
to) NCEP:) ATP) III) definition) of) 46.9) %) and) by) IDF) definition) 49.7) %) in) men,) and) in)
women)35.5)%)and)42.2)%,) respectively) (Hu)et) al.,) 2008).)With)a) global) increase) in)
obesity) and) aging,) it) has) been) hypothesized) that) there) will) be) a) rise) in) MetS)
prevalence)rates)in)the)future)(Eriksson)et)al.,)1997).)
2.4.2 PATHOPHYSIOLOGY!
Both) central) obesity) and) insulin) resistance) play) important) roles) in) the)
pathophysiology)of)MetS)(Cameron)et)al.,)2008;)Eckel)et)al.,)2005;)Eckel)et)al.,)2010).)
Increased) amounts) of) adipose) tissue) are) associated) with) higher) rates) of) adipose)
tissue[derived) free) fatty) acids) and) cytokines) including) interleukin) (IL)) [6,) tumor)
necrosis) factor) (TNF)) [α) and) C[reactive) protein,) which) can) impair) insulin) action) an)
induce)insulin)resistance)(Cameron)et)al.,)2008;)Eckel)et)al.,)2005;)Uysal)et)al.,)1997).))
Further) obesity) and) especially) central) obesity) is) characterized) by) a) decrease) in) the)
concentration) of) adiponectin) (Eckel) et) al.,) 2005;) Weyer) et) al.,) 2001).) Lower)















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































acceleration! of! inflammatory! processes! (Nawrocki! and! Scherer,! 2004).! Further,!
profuse!amount!of!circulating! free! fatty!acids!decreases! insulin!sensitivity! in!muscle!
tissue!by!inhibiting!insulinCmediated!glucose!uptake!and!impairs!glucose!partitioning!
to! glycogen! as! well! as! elevates! lipid! accumulation! in! triglycerides! (Boden! and!
Shulman,! 2002;! Eckel! et! al.,! 2005).! Increased! levels! of! circulating! glucose! and! free!
fatty!acids!elevate!pancreatic! insulin!secretion!leading!to!hyperinsulinemia,!a!sign!of!
insulin! resistance! (Eckel! et! al.,! 2005).! As! long! as! the! pancreatic! βCcell! function! is!
responsive,! hyperinsulinemia! persists! and! fasting! as!well! as! postprandial! glycaemia!
remains!normal!(Eckel!et!al.,!2010).!In!addition,!in!the!liver!free!fatty!acids!stimulates!
and! increase!the!production!of!glucose!and!triglycerides,!and!secretion!of!very! lowC
density! lipoproteins! (Boden! and! Shulman,! 2002;! Eckel! et! al.,! 2005).! A! reduction! in!
highCdensity! lipoprotein! (HDL)! and! an! increment! in! lowCdensity! lipoprotein! (LDL),!
especially! in!small!dense!LDLCparticles,!compose!other! lipid!abnormalities!typical! for!
MetS! (Eckel! et! al.,! 2005).! Hyperinsulinemia,! with! an! effect! on! both! sodium!
reabsorption!and!the!sympathetic!nervous!system,!and!increased!levels!of!circulating!
free!fatty!acids!may!contribute!to!the!elevated!BP!levels!(Eckel!et!al.,!2005;!Eckel!et!
al.,! 2010).! There! are! several! other! underlying! pathogenetic! factors! involved! in! the!
pathogenesis! of! MetS! and! including! sleep! apnea,! chronic! stress,! gut! microbiota,!
intrauterine!environment!and!genetic!predisposition!and!several!still!unknown!factors!




include! abdominal! obesity,! physical! inactivity! and! an! unhealthy! diet! (Eckel! et! al.,!
2005;! Expert! Panel,! 2001;!Martin! et! al.,! 2012).! Successful,!moderate! and! sustained!
weight!reduction!improves!most!risk!factors!associated!with!MetS!and!it!reduces!the!





































reduces! the! risk! of! developing! MetS! (Expert! Panel,! 2001;! Laaksonen! et! al.,! 2002;!
Lakka!et!al.,!2003).! Individuals!at! increased!risk!of!MetS!should!avoid!simple!sugars,!
high! intake! ofdietary! cholesterol,! high! intake! of! saturated! fats! and! trans! fats.!
Individuals! at! high! risk! of!MetS! should! favor! fruits,! vegetables! and!whole! grains! in!
their! diet! (Expert! Panel,! 2001;!Magnusdottir! et! al.,! 2014).! Abnormalities! in! glucose!





the! risk! of!MetS! (Garaulet! and!Madrid,! 2009).! In! Table! 7! risk! factors! for!MetS! are!
presented.! Also! vitamin! D! deficiency! has! been! proposed! to! be! a! contributor! to!




in! physical! activity.! There! is! no! specific! drug! for! the! treatment! of! MetS! available.!
Consequently! individuals!with!MetS!often!need! the!combination!of!drug! therapy! to!
achieve! recommended!goals! regarding!blood!pressure,! glucose! regulation,! and! lipid!
!
! 29!
profile.! A! soCcalled! “polypill”,! which! combines! antiplatelet,! BPC! and! cholesterolC







Expert! Panel,! 2001).! According! to! several! studies,! physical! activity! has! beneficial!
effects!on!different!components!of!MetS!in!most!individuals.!These!beneficial!effects!
include!reduction! in!body!weight!and!visceral! fat!accumulation! (Aadahl!et!al.,!2007;!
Philipsen!et!al.,!2014;!Rice!et!al.,!1999;!Smith!et!al.,!2013),!increase!in!HDLCcholesterol!
and! decrease! in! triglyceride! levels! ! (Haskell,! 1986;! Kraus! et! al.,! 2002;! Kujala! et! al.,!
2013;! Thune! et! al.,! 1998),! decrease! in! BP! levels! (Cornelissen! and! Fagard,! 2005a;!
Cornelissen! and! Fagard,! 2005b;! Fagard,! 2005;! Pescatello! et! al.,! 2004),! and!
improvements!in!glucose!metabolism!!(Balducci!et!al.,!2014;!Hu!et!al.,!2003;!Kujala!et!
al.,!2013;!Rice!et!al.,!1999).!
The! effects! of! physical! activity! on! body! weight! and! body! composition! have! been!
investigated!abundantly.!Aerobic!training!seems!to!decrease!total!body!weight!as!well!
as!abdominal!and!visceral!fat!(Boudou!et!al.,!2003;!Church!et!al.,!2010;!Ku!et!al.,!2010;!
Sigal! et! al.,! 2007;! Swift! et! al.,! 2014;! Venojarvi! et! al.,! 2013).! Whereas! resistance!
training!may!not!have!any!essential!effects!on!total!body!weight!but!increases!muscle!
mass!and!decreases!both!abdominal! and!visceral! fat! (Church!et! al.,! 2010;!Ku!et! al.,!
2010;!National!Diabetes!Data!Group,!1979;!Pownall!et!al.,!2015;!Swift!et!al.,!2014).!As!
for! combined! training,! it! may! reduce! total! body! weight! but! the! outcomes! on!
abdominal!and!visceral!fat!are!less!consistent!(Church!et!al.,!2010;!Sigal!et!al.,!2007;!
Swift!et!al.,!2014).!However,!the!level!of!physical!activity!seems!to!have!an!opposite!




body! is! complex! and! incompletely! understood.! Possibly,! physical! activity! influences!






HDLCcholesterol! increases!and! triglycerides! concentration!decreases! ! (Haskell,! 1986;!
Kraus!et!al.,!2002;!Kujala!et!al.,!2013;!Thune!et!al.,!1998).!Exercise!training!seems!to!
induce!increase!in!lipoprotein!lipase!activity!and!decrease!in!hepatic!lipase,!which!has!
beneficial! effect! on! HDLCcholesterol! (Haskell,! 1986;! Nikkila! et! al.,! 1978).! Further,!
exercise!may!reduce!HDL!apoprotein!catabolism!thus!enabling!longer!biological!halfC
life!of!HDL!protein(Haskell,!1986;!Herbert!et!al.,!1984).!Decrease!in!triglycerides!due!
to! exercise,! probably! results! from! increase! in! lipoprotein! lipase! activity,! enhances!
triglyceride! catabolic! capacity! (Haskell,! 1986;! Lampman! and! Schteingart,! 1991).!
Further,!individuals!with!vigorous!physical!exercise!seem!to!have!favorable!changes!in!
LDLCcholesterol!levels!(Kraus!et!al.,!2002).!!
The! effects! of! physical! activity! on! glucose!metabolism! as!well! as! on! BP! have! been!
discussed!previously.!
The! amount! of! LTPA! seems! to! be! inversely! associated! with! the! prevalence! and!
incidence!of!MetS,!also!among!the!elderly!(Bianchi!et!al.,!2008;!Brien!and!Katzmarzyk,!
2006;! Churilla! and! Fitzhugh,! 2009;! Clarke! and! Janssen,! 2013;! Earnest! et! al.,! 2014;!
Laaksonen! et! al.,! 2002;! Nelson! et! al.,! 2013).! The! daily! amount! of! time! engaged! in!
moderate! to! vigorous! physical! activity! is! strongly! associated! with! better! insulin!
sensitivity! (Nelson! et! al.,! 2013).! Further,! several! short! bouts! of! exercise! have! been!






NonCalcoholic! fatty! liver! disease! (NAFLD)! is! defined! as! fat! accumulation! in! the! liver!
exceeding! 5! –! 10! %! of! liver! weight,! in! individuals! with! daily! alcohol! consumption!!!!!!!!!!
<!20!g!and!without!evidence!of!other!causes!of!liver!disease!(NeuschwanderCTetri!and!
Caldwell,!2003).!Liver!fat!content!can!be!determined!by!biopsy!or!by!proton!magnetic!
resonance! spectroscopy! (Kotronen! et! al.,! 2009;! Siegelman! and! Rosen,! 2001).!
However,! these! techniques! are! not! commonly! available! in! general! clinical! practice.!
Most!commonly!used!liver!function!tests,!serum!alanine!aminotransferase!(ALT)!and!
aspartate!aminotransferase! (AST),!are! insensitive!and!nonspecific!markers!of!NAFLD!
(Clark! and! Diehl,! 2003;! Kotronen! et! al.,! 2009).! Therefore! several! scores! have! been!
developed!in!order!to!identify!and!diagnose!NAFLD.!One!of!the!NAFLD!liver!fat!scores!






















The!underlying!pathogenesis! of!NAFLD! is! incompletely! understood.! Individuals!with!
NAFLD! may! be! normal! weigh,! overweight! or! obese! but! they! usually! have! central!
adiposity! (Bhatia! et! al.,! 2012;! NeuschwanderCTetri! and! Caldwell,! 2003).! Further,!
individuals! with! NAFLD! are! likely! to! be! insulin! resistant.! This! is! linked! to! elevated!
levels!of!free!fatty!acids!and!elevated!levels!of!proinflammatory!cytokines!like!TNFCα!
as!well! as! reduced! levels! of! adipokines! such! as! adiponectin! and! leptin! (Levene! and!
Goldin,! 2012;! NeuschwanderCTetri! and! Caldwell,! 2003).! As! a! consequence! of! these!
unfavorable! metabolic! characteristics,! ectopic! fat! is! accumulating! in! organs! like!
skeletal! muscle! and! heart,! hyperinsulinemia! develops,! as! well! as! endothelial!
dysfunction,! dyslipidemia! and! hypercoaguability,! all! increasing! the! risk! of!
cardiovascular!disease!(Bhatia!et!al.,!2012).!!!
The! development! from!NAFLD! to! progressive! fibrotic! nonCalcoholic! steatohepatitis,!
and!further!to!hepatic!cirrhosis!is!a!result!of!multiple!metabolic!abnormalities!taking!
place! in!a! favorable!genetic!environment!(Levene!and!Goldin,!2012;!NeuschwanderC
Tetri! and! Caldwell,! 2003).! The! reason! why! liver! disease! develops! within! some!
individuals!but!not!in!others!is!not!clear;!this!could!be!due!to!high!levels!of!circulating!
free! fatty! acids! but! also! genetic! factors! seem! to! be! important! (Levene! and!Goldin,!
2012;! NeuschwanderCTetri! and! Caldwell,! 2003;! Vernon! et! al.,! 2011).! Of! individuals!
with!NAFLD,!approximately!30!%!will!progress!to!nonC)alcoholic!steatohepatitis!and!of!


































2000).! Furthermore,! individuals! with! both! T2D! and! NAFLD! may! have! a! more!
progressive!liver!disease!(Prashanth!et!al.,!2009;!Vernon!et!al.,!2011).!Study!findings!
regarding! gender! differences! are! conflicting,! albeit! recent! observations! show!male!
gender!to!be!a!risk!factor!for!NAFLD!(Chen!et!al.,!2008;!Sandboge!et!al.,!2013;!Vernon!
et! al.,! 2011).! Race! and! ethnicity! are! associated! with! the! occurrence! of! NAFLD,!
possible! because! of! genetic! factors! (Chalasani! et! al.,! 2012;! Vernon! et! al.,! 2011).!










et! al.,! 2009;! van! der!Heijden! et! al.,! 2010).! There! are! also! observations! showing! no!
associations!with!exercise!and! reduced! fat! content! in! the! liver! (ShojaeeCMoradie!et!









Telomeres! are! regions! of! repetitive! nucleotide! sequences! (TTAGGG)! bounded! by!
specific!proteins!at!the!chromatid!ends!of!eukaryotic!chromosomes!(Blackburn!et!al.,!
2006;!Moyzis! et! al.,! 1988).! Primarily,! telomerase!enzyme! regulates! telomere! length!
(Blackburn! et! al.,! 2006).! The! length! of! the! repeats! differs! between! each! individual!
chromosome!and!between!species!being!in!humans!remarkably!variable!(Baird!et!al.,!
2003;!Blackburn!et!al.,!2006;!Lansdorp!et!al.,!1996).!Telomeres!have!an!essential!role!




cells!or!genomic!DNA! (Starkweather!et!al.,! 2014).!The! terminal! restriction! fragment!








is! situ! hybridization! methods! are! feasible! when! the! investigation! includes! small!




2013;! Shammas,! 2011).! Further,! telomere! length! is! highly! heritable,! the! estimates!
varying! between! 44! %! and! 80! %! (Njajou! et! al.,! 2012;! Starkweather! et! al.,! 2014).!
Although!maternal!inheritance!seems!to!be!strong,!also!paternal!age!affects!telomere!





Oxidative! stress! and! systematic! inflammation! seems! to! be! associated! with! shorter!
telomeres.!Shorter! telomere! length!has!been!associated!with!and! increased! risk! for!
several!chronic!nonCcommunicable!diseases!including!T2D!and!cardiovascular!disease!
(Salpea!and!Humphries,!2010;!von!Zglinicki,!2002;!von!Zglinicki!and!MartinCRuiz,!2005;!






associated! with! longer! telomeres! (CrousCBou! et! al.,! 2014).! Moreover,! depression,!
psychological! stress,! poor! sleep! quality! and! low! educational! attainment! have! been!





Commonly!moderate! levels! of! physical! activity! has! been! linked! to! longer! telomere!
length! (Kim!et! al.,! 2012;!Mirabello! et! al.,! 2009).!However,! the! association! between!
physical!training!and!telomere!length!has!been!unequivocal!(Ludlow!et!al.,!2013).! In!
most! studies! focusing!upon!exercise!and! telomere! length! the!mode!of!exercise!has!
been! endurance! or! aerobicCtype! training.! The! findings! have! been! inconclusive! and!
positive!associations! (Cherkas!et!al.,!2008;!Du!et!al.,!2012;!LaRocca!et!al.,!2010);!no!




length! (Kadi! et! al.,! 2008).! However,! it! has! been! observed! negative! associations!
between! heavyCresistance! training! and! telomere! length! when! telomeres! are!
measured!from!skeletal!muscles!(Kadi!et!al.,!2008).!!
At! present,! the! underlying! mechanisms,! by! which! physical! activity! has! effects! on!
telomere! length! and! why! the! responses! are! ambiguous,! are! unknown.! Possibly,!
oxidative! stress,! expression! of! telomere! stabilizing! proteins,! growthC! and! stressC
related! hormones! and! their! associated! pathways! composed! the! remarkable! factors!
(Carrero!et!al.,!2008;!Cherkas!et!al.,!2008;!Ludlow!and!Roth,!2011;!Shammas,!2011).!
ShortCterm!exercise! seems! to!have!no! association!with! telomere! length! (Werner! et!
al.,! 2008).! Presumable,! longCterm! or! strenuous! exercise! is! required! in! order! to!
influence!telomere!length!(LaRocca!et!al.,!2010;!Ludlow!et!al.,!2013).!However,!both!
shortCterm! and! longCterm!exercise! seems! to!modulate! telomereCstabilizing! proteins!
thus! at! least! partly! explaining! the! effects! of! physical! activity! (Werner! et! al.,! 2008).!
Furthermore,!methods!which!are!used!for!telomere!length!determination,!cell!types!
which!are!used! for!DNA!extraction,! the!age!variation!of! the! individuals! in! the!study!
cohorts,!small!study!samples!as!well!as!variation!in!collection!of!exercise!and!physical!
activity! data! likely! give! explanations! to! the! discrepancies! in! results! (Ludlow! et! al.,!



















The! original! study! population! (N=4136)! consists! of! male! former! elite! athletes!
(n=2424)!and!their!matched!healthy!controls! (n=1712).!All! study!subjects!were!men!
and!of! European!ancestry.!Male! former!elite! athletes! represented! Finland!between!
the!years!1920!and!1965!at! least!once!in!major! international!competitions! including!
Olympic! games,! World! or! European! championships! or! other! interCcountry!
competitions.! The! controls! were! classified! as! healthy! (class! A1)! at! the! medical!
examination,!which!all!Finnish!men!undergo!at!age!of!20!years!as!part!of!the!national!
military!service.!The!selection!of!controls!was!carried!out!in!the!years!1978C1979!from!
the! register! of! men! liable! for! military! service.! The! controls! were! in! the! same! age!
cohort!and!from!the!same!area!as!the!athletes.!After!that,!ice!hockey!and!basketball!
players!as!well!as!weight!lifters!were!included!but!no!controls!were!chosen!for!them.!!
Male! former! elite! athletes!were!divided! into! three! groups! according! to! the! type!of!
training! needed! to! achieve! optimal! results:! endurance! sports! (long! and! middle!
distance!running,!cross!country!skiing),!mixed!sports! (soccer,! ice!hockey,!basketball,!
track! and! field:! jumpers,! sprinters,! hurdles,! decathletes)! and! power! sports! (boxing,!
wrestling,! weight! lifting,! track! and! field! throwers).! ! The! division! is! based! on! the!
ranking!of!sports!by! the!average!maximal!oxygen!uptake! for!male!athletes! (Åstrand!













questionnaires! sent! in!1985,!1995!or!2001.!By! the!year!2008,!63.9!%!of! the! former!
athletes!and!67.9!%!of!the!controls!had!died.!
In! the! year! 2008! altogether! 1183! subjects! (of! those! 747! former! athletes! and! 436!





In! study! I,! the! study! subjects! (n=1183)! consist! of! 747! former! athletes! and! 436!
controls.!Of!those!599!(392!former!athletes,!207!controls)!participated!in!the!clinical!
study!in!2008.!
In! study! II,! from! the!original! study!population! (n=4136)! those!who!had!died!before!



































register! started,! thus! the! total! number! of! study! participants!was! n=3440! (of! those!








The! clinical! study! consisted! of! a! physical! examination,! laboratory! tests! and!
questionnaires.!!Physical!measurements!and!blood!sampling!were!carried!out!in!local!
health!centres!or!other!survey!sites!by!specially!trained!study!nurses!and!shipped!to!
the! National! Public! Health! Institute! (currently! National! Institute! for! Health! and!
Welfare),!Finland.!If!the!participant!needed!help!to!fill!in!the!questionnaires,!the!study!
nurse!helped!him.!!




BMI!was! calculated! as! body!weight! divided! by! height! squared! (kg/m2).! Height!was!
measured!without!shoes!on!by!a!measuring!tape!against!a!wall!to!an!accuracy!of!0.1!






calculated! as! fat! mass! (kg)! divided! by! body! weight! (kg)! converted! to! percent.! The!
estimation!is!based!on!electrical!impedance,!which!enables!to!estimate!fatCfree!body!
mass! and! body! fat! mass.! Participants! with! a! pacemaker! (n=14)! had! a! weight!
measurement!with!a!digital! scale!with!accuracy!of!0.1! kg.!Waist! circumference!was!
measured!midway!between!the!anterior!superior!iliac!spine!and!lower!edge!of!the!rib!
cage! in!a! relaxed!standing!posture.!Eighteen!participants!had!missing!data! for!body!
composition,!and!two!participants!for!waist!circumference.!
After! at! least! five! minutes! of! rest,! the! study! nurse! measured! BP! with! a! mercury!
sphygmomanometer! (Riester! Diplomat,! Jungingen,! Germany)! from! the! participant’s!
right!arm!using!a!cuff!size!of!14.5!cm!x!54.5!cm!in!a!sitting!position.!BP!was!measured!
twice! and!between! the!measurements! there!was! at! least! a! oneCminute! pause.! The!
mean!of! two!BP!values!was!reported!and!used! in! the!calculations!of!pulse!pressure!
(systolic!BP!–!diastolic!BP)!and!the!mean!arterial!pressure!(diastolic!BP!+!1/3!x!pulse!




In! the! morning! after! ten! hours! of! fasting,! venous! blood! samples! were! taken! in! a!
sitting! position.! The! blood! samples! were! centrifuged! at! the! field! survey! sites.! The!
plasma!and! serum!were! frozen! immediately! after! separating!and! transferred! in!dry!
ice! to! the! laboratory! once! a!week! for! analyses! to!National! Institute! for!Health! and!
Welfare,!Finland.!The!laboratory!analysis!were!performed!by!following!methods:!for!
plasma! glucose! enzymatic! hexokinase! assay! (Abbott! Laboratories),! for! total!
cholesterol!enzymatic!assay!(Abbott!Laboratories),! for!direct!measurement!of!HDL!–
cholesterol! homogenous! assay! (Abbott! Laboratories),! for! triglycerides! enzymatic!
glycerol!phosphate!oxidase!assay!(Abbott!Laboratories),! for!high!sensitive!CCreactive!
protein! latex! immunoassay! (Sentinel! Diagnostics,! Milan,! Italy),! for! ALT! and! AST!
International! Federation! of! Clinical! Chemistry! method! (Abbott! Laboratories),! for!
!
!42!
insulin! chemiluminescent! microparticle! immunoassay! (CMIA,! Abbott! Laboratories),!
for!high!molecular!weight! (HMW)!adiponectin! and! ILC1! receptor! antagonist! enzyme!
linked! immunosorbent!assays! (Human!HMW,!Adiponectin!ELISA,!Millipore,!USA!and!
Quantikine!Human! IL1ra,!R&D!Systems!USA),! for! ILC1!beta,! ILC6!and!TNFCα!multiplex!
sandwich! immunoassay! (Milliplex! High! Sensitivity! Human! Cytokine! kit,! Millipore,!
USA).!Of! the! results!of! ILC1!beta! there!were!88.3!%!under!measurements! level! and!
further! analysis! was! not! done.! LDL! Ccholesterol! was! calculated! by! the! Friedewald!
formula! (Friedewald! et! al.,! 1972).! Four! participants! had! missing! data! on! insulin!
measurement,! and! two!participants!on!HMW!adiponectin,! ILC1! receptor!antagonist,!
ILC1!beta,!ILC6,!and!TNFCα!measurements.!!
Participants! without! a! history! of! diabetes! underwent! a! 75! g! standard! 2Chour! oral!
glucose! tolerance! test! according! to! the!WHO! 1999! guidelines! (Alberti! and! Zimmet,!
1998).!A!blood!sample!was!drawn!at!baseline!and!at!2!hours!after!the!ingestion!of!the!
300! ml) solution,! containing! 75! g! anhydrous! glucose! and! 1.6! g! citric! acid.! Three!
participants!had!missing!data!from!the!2Chour!oral!glucose!tolerance!test.!
LTL! was!measured! from! DNA! extracted! from! peripheral! blood! using! a! quantitative!
realCtime! polymerase! chain! reaction! (Cawthon,! 2002b),! as! described! previously!
(Eerola!et!al.,!2010;!Kananen!et!al.,!2010;!Kao!et!al.,!2008).!βChemoglobin!was!used!as!
a! single! copy! reference! gene.! Separate! reactions! for! telomere! and! βChemoglobin!




Manager! software!was!used! to!perform!quality! control,! and! samples!with! standard!



































Structured! and! selfCreported! questionnaires! were! used! to! get! the! information! on!
smoking! status,! consumption! of! alcohol,! educational! attainment! as! well! as! marital!
status! (Peltonen! et! al.,! 2008).! Participants! were! considered! smokers! if! they! had!
smoked!over!100!cigarettes!in!their!lifetime!and!still!smoked!daily!or!almost!daily!at!
least!one!cigarette!or!quit!smoking! less!than!six!months!ago.! !The!participants!were!
classified! as! heavy! alcohol! users,! if! they! reported! using! 288! g! or!more! alcohol! in! a!
week.!Educational!attainment!was!defined!according!to!how!many!years!of!schooling!
had! been! completed,! and! categorized! into! following! sosioCeconomic! status! (SES)!
classes:!SES!I!(low!degree!of!education)!less!than!10!years,!and!SES!II!(middle!degree!
of!education)!10C12!years,!and!SES!III!(high!degree!of!education)!13!years!or!more.!As!
for!marital! status,! the! participants!were! divided! into! single,! separated! or!widowed!
and!married!or!cohabiting.!Nine!participants!had!missing!data!for!smoking!habits,!and!
32! participants! for! consumption! of! alcohol,! and! four! participants! for! educational!
attainment,!and!one!participant!for!marital!status.!!
4.3 ASSESSMENT) OF) IMPAIRED) FASTING) GLUCOSE,) IMPAIRED)
GLUCOSE)TOLERANCE)AND)TYPE)2)DIABETES)IN)STUDIES)I@III)
The!study!subjects!(n=3636)!were!considered!having!diabetes!if!they!were!entitled!to!
reimbursable!medication! for! diabetes.! The! participants! (n=599)! of! the! 2008! clinical!
study!who! reported!having!diabetes!or!diabetes!medication!were!classified! to!have!
selfCreported! diabetes.! The! participants,! whose! diabetes! was! diagnosed! by! a! 75! g!
standard!2Chour!oral!glucose!tolerance!test,!were!classified!to!have!screenCdetected!
diabetes.!WHO!criteria!from!the!year!1999!(Alberti!and!Zimmet,!1998)!were!used!to!





The! study! subjects! (n=3440)! were! considered! having! hypertension! if! they! were!
entitled! to! reimbursable! medication! for! hypertension.! The! participants! (n=599)! of!
2008! clinical! study! were! defined! to! have! hypertension! if! they! had! reimbursable!




The! participants! (n=599)! of! the! clinical! study! in! 2008! were! defined! to! have! MetS!







The! participants! (n=599)! of! the! clinical! study! in! 2008!were! defined! to! have!NAFLD!
with! liver! fat! score! (based! on! five! variables:! presence! of! MetS,! presence! of! T2D,!
fasting!serum!insulin,!ALT!and!AST/ALT!ratio)!values!greater!than!C0.640.!This!cutCoff!
point! is! shown! to! predict! NAFLD!with! high! sensitivity! and! specificity! in! the! Finnish!
population!(Kotronen!et!al.,!2009).!
4.7 STATISTICAL)ANALYSIS)
Data!are! reported!as!means!±! standard!deviations! (SD)!or!percentage!and!number.!
Percentage! differences! were! tested! using! crossCtabulation! and! ChiCSquare! test.!
!
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Logistic! regression! was! used! to! estimate! the! odds! ratio! (OR)! and! 95%! confidence!
interval! (CI).! Means! were! compared! by! oneCway! ANOVA,! and! post! hoc! tests! by!
Bonferroni! correction.! Adjusting! with! other! variables! was! done! by! general! linear!
model.!Age,!BMI,!LTPA,!smoking!habits,!alcohol!consumption,!educational!attainment!
and/or!marital! status!were!used!as!covariates.! In! study! IV,! correlation!was!assesses!
using! the! Pearson! correlation! analysis! for! continuous! variables! and! using! the!







In! the! clinical! study!performed! in!2008! (n=1183),! the!participation! rate!was!52.5!%!
among!all!athletes,!52.9!%!among!the!endurance!athletes,!55.8!%!among!mixed!group!
athletes,! 46.5! %! among! the! power! athletes,! and! 47.5! %! among! the! controls,!
respectively.!The!participants!(n=599)!were!significantly!younger,!mean!(SD)!age!72.3!
(5.9)!years,!than!the!nonCparticipants,!(n=584)!mean!age!74.9!(7.3)!years!(p!<0.001).!
5.2 BASIC) CHARACTERISTIC)OF) THE) PARTICIPANTS) IN) THE) YEAR) 2008)
CLINICAL)STUDY)
Mean!(SD)!age!of! the! former!athletes!was!72.7! (6.1)!years,!and!that!of! the!controls!
was! 71.6! (5.6)! years! (p=0.024).! The! endurance! athletes!were! the!oldest! ones,! their!
mean!age!being!75.3!(5.5)!years!(p<0.001!compared!to!the!controls).!Mean!(SD)!BMI!
of! the! former! athletes!was! 26.5! (3.9)! kg/m2!while! the! corresponding! value! for! the!
controls!was!26.8!(3.4)!kg/m2!(p=0.285).!The!endurance!athletes!had!the!lowest!BMI,!
mean!BMI!25.0! (3.3)! kg/m2! (p<0.001! compared! to! the! controls).!Among! the! former!
athletes! the! mean! (SD)! volume! of! LTPA! was! 31.4! (28.5)! METCh/week! and! the!
corresponding!value!among!the!controls!was!20.5!(21.7)!METCh/week!(p<0.001).!The!
endurance! athletes! had! the! highest! volume! of! LTPA,! mean! LTPA! being! 42.8! METC
h/week! (36.62)! (p<0.001! compared! to! the! controls).! Of! the! former! athletes! 5.1! %!
were! smokers! and! 10.4! %! of! the! controls,! respectively! (p=0.014).! ! No! significant!
differences!were!observed!between!the!groups!regarding!to!heavy!alcohol!users.!!The!
male! former! elite! athletes! had! significant! higher! educational! attainment! than! the!
controls:!30.1!%!of!the!former!athletes!belonged!to!the!highest!social!class!(SES! III),!
the!corresponding!number!among!the!controls!was!14.6!%!(p<0.001).!There!was!no!






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure' 5.'Prevalence! of! type! 2! diabetes! based! on! reimbursable! diabetes!medication! in! the!
original!study!population!(n=3636).!P@values!compared!to!the!controls!
5.3 IMPAIRED' FASTING' GLUCOSE,' IMPAIRED' GLUCOSE' TOLERANCE'
AND'TYPE'2'DIABETES'(STUDY'I)''
Information! of! reimbursable! diabetes! medication! in! the! original! study! population!
(excluding!those!who!had!died![n=410]!before!year!1964!when!the!register! initiated!
or!whose!status!was!unknown![n=90],!thus!in!total!n=3636),!showed!a!trend!toward!a!
lower! age@adjusted!prevalence!of! T2D!among! the! former! athletes! compared! to! the!
controls,!the!OR!being!0.82!(95%!CI!0.66@1.03).!Focusing!individually!at!the!different!
groups!of!athletes!the!age@adjusted!OR!among!the!endurance!athletes!was!0.52!(95%!
CI! 0.33@0.83),! compared! to! the! controls.! The! corresponding!OR! in! the!mixed! group!
athletes!was!0.70!(95%!CI!0.52@0.94),!and!that!in!the!power!group!athletes!was!1.11!
(95%! CI! 0.85@1.46)! compared! to! the! controls,! respectively.! Figure! 5! shows! the!
prevalence! of! T2D!based! on! data! on! reimbursable! diabetes!medication! in! different!
athlete!groups!and!in!the!control!group.!
Among! the!participants! in! the!clinical! study! (n=599)! the!prevalence!of! self@reported!

























than! among! the! controls! (OR! 0.68,! 95%! CI! 0.45@1.01).! The! former! ahletes! in! the!
endurance! group! had! significantly! lower! age@adjusted! prevalence! of! T2D! than! the!
controls!(OR!0.43,!95%!CI!0.20@0.94).!After!further!adjustment!for!current!volume!of!
LTPA! no! significant! association! was! observed! between! the! groups! of! athletes! and!
controls.!!
The!age@adjusted!prevalence!of!IGT!was!significantly!lower!among!the!former!athletes!
than! among! the! controls! (OR! 0.57,! 95%! CI! 0.38@0.86).! After! further! adjustment!
including! current! volume! of! LTPA! the! result! remained! significant! (OR! 0.62,! 95%! CI!
0.49@0.95).!
The! clinical! study! participants! received! significantly! less! reimbursable! diabetes!
medication!than!the!non@participants!(8.3!%!vs!12.8!%,!p<0.001).!
Table! 12! shows! the! prevalence! of! IFG,! IGT! and! T2D! among! participants! classified!
according!to!volume!of!current!LTPA.!Participants!with!high!level!of!current!LTPA!had!
significantly!lower!age@adjusted!prevalence!of!T2D!compared!to!participants!with!low!
level! of! current! LTPA! (p@value! for! trend! <0.001).! Further! adjustment! for! age,! BMI,!
smoking,!SES!and!athletic!group,!attenuated!the!finding!(p@value!for!trend!0.042).!!























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































or!whose!status!was!unknown![n=90],! thus! in! total!n=3440),!no!significant!difference!was!
observed!in!ageHadjusted!prevalence!of!hypertension!between!the!former!athletes!and!the!
controls,! the! OR! being! 0.93! (95%! CI! 0.80H1.10).! Similarly! no! significant! differences! were!
observed!between!the!different!athlete!groups!and!controls!(endurance!athletes!vs!controls!
ageHadjusted!OR!0.85!(95%!CI!0.64H1.13),!mixed!group!athletes!and!controls!OR!0.87!(95%!CI!
0.71H1.06),! power! group! athletes! and! the! controls! OR! 1.06! (95%! CI! 0.86H1.30).! Figure! 6!




medication! or! selfHreported! current! use! of! antihypertensive!medication)!was! significantly!
lower! among! the! former! athletes! than! among! the! controls! (OR! 0.69,! 95%! CI! 0.49H0.98).!
Further,!the!former!ahletes!from!the!endurance!group!had!significantly!lower!ageHadjusted!
prevalence! of! hypertension! (based! on! reimbursable! antihypertensive! medication! or! selfH
reported!current!use!of!antihypertensive!medication)!than!the!controls!OR!being!0.43!(95%!
CI! 0.23H0.80).! The! lowest! prevalence! of! hypertension! was! observed! among! the! former!
athletes! in! the! endurance! group! also!when! clinically!measured!BP! levels!were! taken! into!
account! ! (ageHadjusted!OR! 0.41,! 95%!CI! 0.22H0.74! compared! to! the! controls).! The! results!
remained!significant!after!further!adjustment!including!current!volume!of!LTPA!among!the!
former!endurance!athletes!(OR!0.50,!95%!CI!0.25H0.99!compared!to!the!controls).!!








Among! participants! without! BP! lowering! medication! (n=319),! the! former! athletes! had!
significantly!lower!systolic!BP!(139.2!mmHg![SD18.7]!vs!144.2!mmHg![SD!19.5],!p=0.027)!and!
pulse!pressure!(59.4!mmHg![SD!15.4]!vs!63.5!mmHg![SD!16.4],!p=0.028)!than!the!controls.!




ageHadjusted! prevalence! of! hypertension! (based! on! reimbursable! antihypertensive!
medication! or! selfHreported! current! use! of! antihypertensive! medication)! compared! to!
participants!with! low! level! of! current! LTPA! (pHvalue! for! trend!<0.011).!Among! the! clinical!
study!participants!without!blood!pressure!lowering!medication!(n=319),!no!association!was!








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































athletes!had! significantly! lower!body! fat!percentage!compared! to! the! controls,! (p=0.021).!
The! lowest! body! fat! percentage! was! observed! in! the! mixed! group! athletes,! (p=! 0.009!
compared! to! the! controls).! Table!15! shows! the!distribution!of! fat! free!mass!and!body! fat!
percentage! among! participants! divided! into! different! athlete! and! control! groups.!
Participants! with! high! level! of! current! LTPA! had! significantly! lower! body! fat! percentage!
compared! to! participants! with! low! level! of! current! LTPA! (p5value! for! trend! <0.001).!
However,!no!significant!associations!were!observed!between!current!volume!of! LTPA!and!
fat!free!mass!(p5value!for!trend!0.506).!
The! male! former! athletes! had! significantly! lower! age5adjusted! prevalence! of! MetS!
compared!to!the!controls!(OR!0.57,!95%!CI!0.4050.81).!The!results!remained!significant!after!
further! adjustment! for! BMI,! LTPA,! smoking,! alcohol! intake,! educational! attainment! and!
marital! status.! The! former!endurance!athletes!had! the! lowest!age5adjusted!prevalence!of!
MetS,!compared!to!the!controls!the!OR!being!0.28!(95%!CI!0.1650.52).!Table!16!shows!the!
prevalence!and!risk!for!MetS!among!participants!divided!into!different!athlete!and!control!
groups.! Participants! with! high! level! of! current! LTPA! had! significantly! lower! age5adjusted!
prevalence! of!MetS! compared! to! participants!with! low! level! of! current! LTPA! (p5value! for!
trend! <0.001).! After! further! adjustment! for! BMI,! smoking,! alcohol! intake,! educational!
attainment!and!marital!status,!no!significant!differences!were!observed!(p5value! for! trend!
0.290).!
With! regard! to! lipids! and! cytokines! (total,! LDL5! and! HDL5! cholesterol,! triglycerides,!
lipoprotein!apo!A1,!lipoprotein!apo!B,!high5sensitive!C5reactive!protein,!HMW!adiponectin,!
IL51!beta,!IL51!receptor!antagonist,!IL56!and!TNF5α)!no!significant!differences!were!observed!




high! sensitive!C5reactive!protein! (p5value! for! trend!<0.001)! compared! to!participants!with!
low!level!of!current!LTPA!(Table!17).!
The!former!athletes!had!significantly!lower!age5adjusted!prevalence!of!NAFLD!compared!to!
the! controls! (OR! 0.61,! 95%! CI! 0.4250.88).! They! also! showed! the! lowest! age5adjusted!
prevalence!of!NAFLD,!compared!to!the!controls!the!OR!being!0.29!(95%!CI!0.1550.56).!Table!
16! shows! the! prevalence! and! risk! for! NAFLD! among! participants! divided! into! different!






An! inverse! association! was! observed! between! age! and! LTL! (r=50.119,! p=0.004).! No!
statistically! significant!associations!were!observed!with! the!other!assessed! covariates!and!
LTL:!fat!free!mass!(r=0.028,!p=0.511),!LTPA!(r=0.058,!p=0.164),!smoking!(r=0.015,!p=0.936),!
alcohol! intake! (r=0.005,! p=0.897),! high! sensitive! C5reactive! protein! (r=50.007,! p=0.859),!
educational! attainment! (r=0.018,! p=0.453),! and! marital! status! (r=0.026,! p=0.148).! No!
significant! differences!were! observed! in!mean! age5adjusted! LTL! between! the! athlete! and!



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































! All!athletes! Endurance! Mixed! Power!
IFG! F! F! F! F!
IGT! ↓! F! ↓ F!
T2D! (↓) ↓ F! F!
BP! ↓ ↓ F! F!
BMI! - ↓ F! ↑!
Fat!free!mass! ↑ - ↑! ↑ 
Body!fat!%! ↓ ↓ ↓ F!
MetS! ↓ ↓ F! ↓!
NAFLD! ↓ ↓ (↓)! F!
LTL! F! F! F! F!
IFG!=! impaired! fasting!glucose;! IGT!=! impaired!glucose! tolerance;!T2D!=! type!2!diabetes;!BP!=!blood!
pressure;! MetS! =! metabolic! syndrome;! NAFLD! =! nonFalcoholic! fatty! liver! disease;! LTL! =! leukocyte!
telomere!length!
!




















The! present! study! investigated! the! associations! of! vigorous! physical! activity! during!
young!adulthood!in!men!with!their!cardiometabolic!health!in!later!life.!!
The!athletes!from!the!endurance!and!mixed!groups!had!lower!prevalence!of!T2D!than!
their! matched! controls! in! later! life.! Further,! the! male! former! athletes! had! lower!
prevalence! of! IGT! than! the! controls.! Moreover,! the! participants! with! the! highest!
levels! of! LTPA! in! later! life! had! the! lowest! prevalence! of! T2D.!With! aging! the!male!
former!athletes!maintained!their!physically!active!lifestyle!better!than!their!controls.!
The! male! former! athletes! also! had! a! lower! prevalence! of! hypertension! than! their!
controls!with!aging.!Those!male!former!athletes!who!had!no!BP!lowering!medication!
had! lower! systolic! BP! than! the! controls.! The! participants!with! the! highest! levels! of!
LTPA!in!later!life!had!the!lowest!prevalence!of!hypertension.!
The! former! athletes! also! had! lower! body! fat! percentage! and! lower! prevalence! of!
MetS! and! NAFLD! than! their! controls! in! later! life.! Participants! with! high! volume! of!
LTPA!in!late!life!had!the!lowest!body!fat!percentage!and!the!lowest!risk!for!MetS!and!
NAFLD.!!
With! regard! to! later! life! LTL,! there! were! no! differences! between! the! athlete! and!
control! groups.! Participants’! current! volume! of! LTPA! had! no! influence! on! LTL.!
Participants’! age! was! inversely! associated! with! LTL! as! expected! (Muezzinler! et! al.,!
2013).!
Taken! together,! vigorous! physical! activity! during! young! adulthood! had! a! beneficial!
association!with! cardiometabolic! health! in! later! life.! The!male! former! elite! athletes!
continued! their! physically! active! lifestyle! more! often! than! their! controls.! Later! life!
high! volume! of! LTPA! also! had! favorable! associations! with! cardiometabolic! health.!
These!findings!are!consistent!with!previous!findings!showing!a!favorable!association!





Tuomilehto! et! al.,! 2001).! Further,! these! study! findings! are! in! line! and! endorse! the!
recent! findings! from!the! same!study!cohort! showing! that!elite!athletes!have! longer!
life!expectancy!compared!with!men!who!where!classified!healthy!as!young!adults!as!
well! as! with! study! findings! of! Olympic! medalist! longevity! (Clarke! et! al.,! 2012;!
Kettunen!et!al.,!2014).!!!







The!male! former! elite! athletes! having! a! history! of! vigorous! physical! activity! during!




who!took!most!LTPA! in! later! life!had!the! lowest!prevalence!of!T2D.!Moreover,!with!
aging!the!former!athletes!had!lower!risk!for!IGT!than!their!controls.!!
In! this! clinical! study,!more! than!60!%!of! the!participants!at!mean!age!72!years!had!
abnormal! glucose! regulation.! This! observation! is! consistent! with! the! Finnish!
population! based! survey! where! among! men! aged! 65F74! years! the! prevalence! of!
abnormal! glucose! regulation! was! 55! %! (Peltonen! et! al.,! 2006).! Further,! previous!
findings! from! the! same! male! former! elite! athletes! study! cohort! were! confirmed:!
current! volume!of! LTPA! is! important! in! prevention!of! T2D.!With! increasing! age! the!
!
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former! athletes!maintained! their! physically! active! lifestyle! better! than! the! controls!
(Kettunen!et!al.,!2010;!Kujala!et!al.,!1994;!Sarna!et!al.,!1997).!
With!regard!to!T2D!the!results!of!the!present!study!endorses!several!previous!findings!




Manson,! 2005;! Brouwer! et! al.,! 2010;! Colberg! et! al.,! 2010;! Lindstrom! et! al.,! 2013).!
Aging!is!associated!with!a!loss!of!muscle!mass!and!increased!muscle!weakness,!which!
with! sedentary! lifestyle! leads! to! substantial! impairment! of! muscle! function! thus!
increasing! insulin! resistance! (Unwin! et! al.,! 2002).! The! loss! of! muscle! mass! is! also!
leading! to! a! more! unfavorable! body! composition! with! higher! body! fat! percentage!
with!increasing!age.!With!aging!the!prevalence!of!IGT!is!increasing!more!strongly!than!
the!prevalence!of!IFG!(Qiao!et!al.,!2005;!Unwin!et!al.,!2002).!
Naturally,! overweight! and! obesity! has! a! large! influence! on! the! prevalence! of! T2D:!
among!men!under!75!years,!being!overweight!or!obese!raised!the!risk!for!T2D!two!to!
seven! –fold! (Guh! et! al.,! 2009).! According! to! the! obervations! of! this! study,! the!
endurance! athletes! had! significantly! lower! BMI! than! their! controls! and! moreover,!
those!men!with!most!LTPA!had!significantly!lower!BMI!than!the!others.!!Consequently!
not!only!past!and!present!level!of!physical!activity!but!also!degree!of!adiposity!is!an!
important! factor! in! the! development! of! T2D! and! other! disturbances! in! glucose!
regulation.!
The!underlying!protective!mechanisms!of!physical!activity!are!various,!including!large!
scale! effects! on! metabolism:! regulation! of! body! weight,! reduction! of! adiposity,! a!
more!optimal! body! composition,! better! insulin! sensitivity! and! in! the! elderly! people!
increased!insulin!sensitivity,!better!glucose!tolerance,!increased!capillary!proliferation!
in! muscles,! increased! muscle! mass,! higher! proportion! on! insulinFsensitive! muscle!






Moreover,! there! is! plenty! of! evidence! suggesting! that! lifestyle! changes! including!





no!significant!association!with! IFG! in! later! life.!Anyhow,! it! is!generally!believed! that!
similar!lifeFstyle!modifications!will!benefit!people!with!IFG!as!well!as!people!with!IGT!
(Chae!et!al.,!2012;!Nathan!et!al.,!2007;!Unwin!et!al.,!2002).!!




The!male! former! elite! athletes! having! a! history! of! vigorous! physical! activity! during!
young!adulthood!had!lower!prevalence!of!hypertension!than!their!matched!controls!
in! later! life.! Especially! longF! and! middleFdistance! runners! as! well! as! crossFcountry!
skiers! showed! this! favorable! effect.! In! this! particular! group! of! former! athletes,! the!
lower! risk! for! hypertension! remained! even! after! adjustment! for! present! LTPA.!
Further,! former!athletes!without!BP! lowering!medication!had! lower!systolic!BP!than!
their! controls.! Those! participants! who! took!most! LTPA! in! later! life! had! the! lowest!
prevalence!of!hypertension.!
These! observations! are! consistent! with! findings! among! former! college! students!
(Paffenbarger!et!al.,!1991)!as!well!as!with!previous!findings!in!the!same!study!cohort;!




Based!upon! findings! in! the!Finnish!Health!2000! study!41.0!%!of!men!over!65!years!
have! hypertension! (KTL,! 2004),!which! is! consistent!with! the! findings! in! the! present!
study.!Most!often!among!Finnish!men!systolic!BP!raises!until!80!years!of!age!whereas!
diastolic!BP!decreases!gradually!after!55!years!!(Current!care!Hypertension,!2014).!!
According! to! previous! studies,! endurance,! dynamic! resistance,! and! isometric!
resistance! training!are! related! to! lower!systolic!and!diastolic!BP,!whereas!combined!






athletes! especially! endurance! athletes! without! BP! lowering! medication! had!
significantly!lower!systolic!BP!than!the!controls.!!
Obviously,! overweight! and! obesity! has! an! influence! on! the! prevalence! of!
hypertension:!among!men!under!70!years,!being!overweight!or!obese!raised!the!risk!
for! hypertension! up! to! twoFfold! (Guh! et! al.,! 2009).! In! the! present! study,! the!
endurance!athletes!had!significantly! lower!BMI! than! the!controls!and! the!men!with!
most!LTPA!had!significantly!lower!BMI!than!the!others.!!
Generally,!chronic!physical!activity!seems!to!improve!BP.!These!effects!are!mediated!
by! several! different! mechanisms! including! neurohumoral,! vascular! and! structural!
adaptations!as!well!as!genetic!factors!(Jennings!et!al.,!1986;!Kingwell,!2000;!Kohno!et!
al.,! 2000;!Pescatello! et! al.,! 2004;! Somers!et! al.,! 1991).! In! addition,! exercise! training!
reduces!the!total!adipose!tissue!mass!thus!improving!BP!(Poirier!and!Despres,!2001).!




6.4 VIGOUROUS* PHYSICAL* ACTIVITY* DURING* YOUNG* ADULTHOOD*
AND* BODY* COMPOSITION,* METABOLIC* SYNDROME* AND* NOND
ALCOHOLIC*FATTY*LIVER*DISEASE*IN*LATER*LIFE*
The!male! former! elite! athletes! having! a! history! of! vigorous! physical! activity! during!
young!adulthood!had! lower!body!fat!percentage!and! lower!prevalence!of!MetS!and!
NAFLD! than! their! matched! controls! in! later! life.! Especially! in! relation! to! body! fat!
percentage,! longF! and!middleFdistance! runners,! crossFcountry! skiers,! soccer!players,!
ice!hockey!players,!basketball!players,!and!track!and!field!jumpers,!sprinters,!hurdles!
as!well!as!decathletes!experienced!this!favorable!effect.!This!was!also!true!for!other!
components! of! MetS,! in! longF! and! middleFdistance! runners,! crossFcountry! skiers,!
boxers,!wrestlingers,!weight!lifters,!and!track!and!field!throwers;!and!for!NAFLD,!longF!
and! middleFdistance! runners,! and! crossFcountry! skiers.! Further,! among! the! former!
athletes! the! lower! risk! for!MetS! remained!even! after! adjustment! for! present! LTPA.!
Moreover,!those!participants!who!took!most!LTPA!in!later!life!had!the!lowest!body!fat!
percentage!and!the!lowest!prevalence!of!MetS!and!NAFLD.!!
These! study!observations! are! consistent!with! several! previous! findings! showing! the!
favorable!effects!of!physical!activity!and!enhancement! in!body!composition! (Aadahl!
et!al.,!2007;!Ekelund!et!al.,!2011;!Philipsen!et!al.,!2014;!Smith!et!al.,!2013;!Swift!et!al.,!
2014).! Individuals! with! large! muscle! mass! may! be! misclassified! as! overweight! or!
obese! if!using!only!BMI! to!classify! the!degree!of!adiposity.!Further,! individuals!with!
normal! BMI! and! high! body! fat! percentage! are! at! increased! risk! for! metabolic!
dysregulation! (Oliveros! et! al.,! 2014).! Finally,! the! level! of! physical! activity! seems!
influence!inversely!BMI!and!weist!circumference!(Aadahl!et!al.,!2007;!Philipsen!et!al.,!
2014;!Vissers!et!al.,!2013).!These!results!are! in! line!with! the! findings!of! the!present!
study.!
Almost! 60! %! of! the! participants! at! the! mean! age! of! 72! years! had! MetS.! ! This!
observation! is! consistent!with! a! Finnish! populationFbased! survey!where! among! the!






MetS! consists! of! several! metabolic! abnormalities! where! insulin! resistance! is! one!







Individuals! with! MetS! and/or! NAFLD! are! likely! to! have! chronic! lowFgrade!
inflammation! (RodriguezFHernandez! et! al.,! 2013;! Tilg! and!Moschen,! 2008).! Chronic!
lowFgrade! inflammation! and! longFterm! physical! activity! appear! to! be! inversely!
associated,!and!longFterm!physical!activity! is!commonly!associated!with! lower! levels!
of! high! sensitive!CFreactive!protein! and! ILF6! (de!GonzaloFCalvo! et! al.,! 2012;! Kasapis!
and!Thompson,!2005;!Oberbach!et!al.,!2008).!Obviously,!the!genetic!factors!influence!
on! the! responses! of! exercise! training! in! many! ways! and! potentially! also! the! antiF
inflammatory!effects!of!exercise!(Oberbach!et!al.,!2008).!Moreover,!chronic!physical!
activity!seems!to!have!a!link!with!high!HDLFcholesterol,!particularly!large!HDL!particle!
soze,!and! low! triglyceride!concentration! ! (Kujala!et!al.,! 2013).! ! In! this! clinical! study,!
those!participants!who! took!most! LTPA! in! later! life!had!higher!HDLFcholesterol! and!
lower! ILF1! receptor! antagonist! concentrations! than! the! participants! with! lower!
volume! of! current! LTPA.! However,! between! athletes! and! control! groups! no!
differences! in! lipids! or! cytokines!were! observed.!Unfortunately,! data! on! the! use! of!







Between! the!male! former! elite! athletes!with! a! history! of! vigorous! physical! activity!
during!young!adulthood!and!the!controls,!no!differences!were!observed!in!LTL!later!in!
life.! Further,! participants’! current! volume! of! LTPA! did! not! influence! on! LTL.!
Participants’!age!was!inversely!associated!with!LTL.!
Telomere!length!declines!with!aging!(Njajou!et!al.,!2012;!Shammas,!2011),!which!was!
also! observed! in! this! clinical! study.! Generally,! moderate! level! of! physical! activity!
seems!to!be!associated!with!longer!telomere!length!(Kim!et!al.,!2012;!Mirabello!et!al.,!






Probably,! the!association! is!neutral! in! resistance!training,!and!with!heavyFresistance!
training! negative! (Kadi! et! al.,! 2008).! Further,! according! to! some! studies! exercise!















Former! elite! athletes! have! a!wellFdocumented! history! of! vigorous! physical! activity,!
generally!spanning!from!adolescence!to!late!20s!or!30s.!This!enables!investigation!of!
the! longFterm! effects! of! physical! exercise! in! later! life! without! the! need! to! actually!
measure!physical!exercise!during!young!adulthood.!In!other!words!it!offers!a!natural!
setting!for!studying!longFterm!effects!of!vigorous!physical!activity.!





The! register! data! used! in! the! study! for! assessments! of! T2D! and! hypertension! is!
another!strength!of!this!study!but!at!the!same!time!also!one!weakness.!The!register!
data! is! dependent! upon! T2D! and! hypertension! detection! rates,! but! not! the! most!
sensitive!one!to!detect!T2D!or!hypertension.!However,!the!sensitivity!is!considerably!
improved!due!to!the!longitudinal!desing!of!the!present!study.!Using!a!crossFsectional!
approach! would! propably! have! lead! to! far! lower! prevalence! rates.!With! regard! to!
reimbursement! for! antihypertensive! medication,! the! Finnish! Social! Insurance!
Institution!applies!higher!BP! level! as! the! criteria! for!hypertension! than! the!national!
current!care!guideline!recommends! ! (Current!care!Hypertension,!2014;!KELA,!2014).!
For! this! reason,! people! with! less! severe! hypertension! do! not! have! the! right! for!
reimbursable!medication.!To!avoid!this!bias,!participants!were!also!asked!about!their!
current!use!of!drugs!by!structured!questionnaires.!!







with!direct!measurements!of! LTPA! (Haskell,! 2012;!Prince!et!al.,! 2008;!Wilson!et!al.,!
1986).!However,!on!average!the!reliability!and!validity!of!questionnaires!are!better!in!
groups! than! in! individuals! (Haskell,! 2012).! In! this! study! physical! activities! like!
household! activities! were! not! taken! into! account.! Detailed! information! on! dietary!
habits,!including!sodium!intake,!was!not!available.!!
Regarding!previous!observations! in! the!same!cohort,! the! former!athletes!consumed!
more!vegetables!than!the!controls,!and!soccer!players,!ice!hockey!players,!basketball!
players,! and! track! and! field! jumpers,! sprinters,! hurdles,! decathletes,! boxers,!
wrestlingers,!weight! lifters,! and! track! and! field! thrower! also! consumed!more! fruits!
and!vitamin!supplements,!but!less!highFfat!milk!or!butter!(Fogelholm!et!al.,!1994).!The!
validity!of! selfFreported! smoking!habits!has!been! shown! to!be!high! (Morabia!et! al.,!
2001;! Vartiainen! et! al.,! 2002)! whereas! individuals! easily! underreport! alcohol!
consumption! (Greenfield! and! Kerr,! 2008).! Generally! it! is! known! that! lifestyle,! both!






information! on! the! health! of! these! people.! Further,! data! on! arrhythmias,! including!
atrial! fibrillation! and! flutter,!was! not! available.! According! to! several! study! findings,!
endurance!athletes!with!aging!seem!to!develop!atrial!fibrillation!or!flutter!more!often!
than! controls! (Grimsmo! et! al.,! 2010;! Karjalainen! et! al.,! 1998;! Mont! et! al.,! 2009).!
Furthermore,!these!arrhythmias!might!possibly!have!an!effect!on!BP.!With!the!crossF
sectional! clinical! study! desing,! the! laboratory!measurements!was! done! only! in! one!





Unfortunately,!47.5!%!of! the! former!athletes!and!52.5!%!of! the! controls!were!nonF




avoid! survival! bias,! the! register! data! on! reimbursable!medication! for! diabetes! and!
hypertension!was!collected!from!the!whole!study!population.!!
Finally,! the! former! male! elite! athletes! are! genetically! a! selective! group.! Possible,!
underlying! genetic! pleiotropy! explains! some!of! the! associations! between! eliteFclass!
sports! participation,! body! composition,! metabolic! fitness! and! later! occurrence! of!
metabolic!disorders!(Kujala,!2011).!The!former!eliteFclass!athletes!are!also!a!selective!





The! present! study! investigated! the! associations! of! vigorous! physical! activity! during!
young! adulthood!with! cardiometabolic! health! in! later! life! in!men!with! a! history! of!
being! elite! athletes.! The! underlying! study! hypothesis!was! that! a! career! as! an! eliteF
class!athlete!during!young!adulthood!has!a!protective!and!beneficial!associations!with!
cardiometabolic! health! outcomes! including! T2D,! hypertension,! body! composition,!
MetS!and!NAFLD!in!later!life.!
The!male! former! elite! athletes! have! a! lower! prevalence! of! T2D,! IGT,! hypertension,!
MetS! and! NAFLD! compared! to! their! ageF! and! areaFmatched! controls! in! later! life.!
Further,! a! benecial! association! with! body! composition! was! observed.! The! male!
former! athletes! maintained! a! physical! active! lifestyle! better! than! their! controls.!
Participants! with! high! current! volume! of! LTPA! had! lower! prevalence! of! T2D,!
hypertension,! MetS! and! NAFLD! as! well! as! a! more! beneficial! body! composition.!
However,! there!were!no!observed!differences! in! relation! to! later! life!measured! LTL!
between!the!groups.!!
As!a!practical! implication,!it! is! important!to!support!physical!exercise!including!eliteF




future! research.! Further,! it! would! be! interesting! to! investigate! whether! the! active!
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